CXCR3/CXCL10 interactions in the development of hypersensitivity pneumonitis-Reference-Cited by-同舟云学术

CXCR3/CXCL10 interactions in the development of hypersensitivity pneumonitis

Published:2005-02-22 Issue:1 Volume:6 Page:
ISSN:1465-993X
Container-title:Respiratory Research
language:en
Short-container-title:Respir Res

Author:

Agostini Carlo,Calabrese Fiorella,Poletti Venerino,Marcer Guido,Facco Monica,Miorin Marta,Cabrelle Anna,Baesso Ilenia,Zambello Renato,Trentin Livio,Semenzato Gianpietro

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/1465-9921-6-20.pdf

Reference17 articles.

1. Facco M, Trentin L, Nicolardi L, Miorin M, Scquizzato E, Carollo D, Baesso I, Bortoli M, Zambello R, Marcer G, Agostini C, Semenzato G: T cells in the lung of patients with hypersensitivity pneumonitis accumulate in a clonal manner. J Leukoc Biol 2004, 75:789–804.

2. Semenzato G, Adami F, Maschio N, Agostini C: Immune mechanisms in interstitial lung diseases. Allergy 2000, 55:1103–1120.

3. Kim CH, Broxmeyer HE: SLC/exodus2/6Ckine/TCA4 induces chemotaxis of hematopoietic progenitor cells: differential activity of ligands of CCR7, CXCR3, or CXCR4 in chemotaxis vs. suppression of progenitor proliferation. J Leukoc Biol 1999, 66:455–461.

4. Baggiolini M: Chemokines and leukocyte traffic. Nature 1998, 392:565–568.

5. Luster A: Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998, 228:436–445.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypersensitivity Pneumonitis: A Silent Epidemic?;Current Pulmonology Reports;2024-05-25

2. Inflammatory Cells of the Lung: Lymphoid Cells;Reference Module in Biomedical Sciences;2024

3. Transcriptome analysis for the screening of hub genes and potential drugs in hypersensitivity pneumonitis;Human Gene;2023-09

4. CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance;International Journal of Inflammation;2022-09-17

5. MnO2-melittin nanoparticles serve as an effective anti-tumor immunotherapy by enhancing systemic immune response;Biomaterials;2022-09